Araştırma Makalesi

Cancer Incidence During The Covid-19 Pandemic In A Middle Anatolian City In Turkey

Cilt: 44 Sayı: 3 1 Ekim 2022
Cumhuriyet Tıp Dergisi Kapak
Cumhuriyet Tıp Dergisi
PDF İndir
EN

Cancer Incidence During The Covid-19 Pandemic In A Middle Anatolian City In Turkey

Abstract

Objective: Cancer-related deaths in all countries of the world, including our country, are the second leading cause of deaths after cardiovascular diseases. Covid-19 is a pandemic disease affecting many organs but primarily the lung. The aim of this study is to compare the cancer incidences in the pre-Covid-19 period and during Covid-19 pandemic period in Sivas province by means of age, gender and cancer type distribution of the patients.
Methods: The population of the study consists of the patients who applied to health institutions in Sivas between 01.11.2018 and 30.06.2021 and were diagnosed as cancer for the first time. The main variable of the study was cancer incidence. The time variable was the 16-monthtime period comprising before Covid-19 pandemic and during the pandemic period separately. In addition, patients diagnosed with cancer in both periods wasevaluated and compared according to age groups, gender and the type of cancer.
Results: In this study, the pre-pandemic period and the pandemic period were compared. It was determined that 1355 patients were diagnosed as cancer during the pre-pandemic period and 1720 patients during the pandemic period. The incidence, which was 212.1 per hundred thousand in the previous period, increased to 270.5 per hundred thousand during the 16-month pandemic period.
Conclusion: The incidence of cancer increased during the pandemic period compared to the pre-pandemic period.  

Keywords

Kaynakça

  1. 1. Ministry of Health of the Republic of Turkey. What is Covid-19?.https://covid19.saglik.gov.tr/TR-66300/covid-19-nedir-.html. Cited: September 2021. [Internet].
  2. 2. World Health Organization. https://www.who.int/director-general/speeches/detail/who-director-general-s-opening-remarks-at-the-media-briefing-on-covid-19---11-march- 20204. Updated September 2021. [Internet].
  3. 3. Ministry of Health of the Republic of Turkey. Minister Koca Evaluated Turkey's 1-Year Fight Against Covid-19.https://www.saglik.gov.tr/TR,80604/bakan-koca-turkiyenin-kovid-19la-1-yillik-mucadele-surecini-degerledi.htmlUpdated:September 2021. [Internet].
  4. 4. Öğütlü H. Turkey's response to COVID-19 in terms of mental health. Ir J Psychol Med. 2020; 37(3):222-225.
  5. 5. Czeisler MÉ, Marynak K, Clarke KE, Salah Z, Shakyaet I, Thierry JM, et al. Delay or Avoidance of Medical Care Because of COVID-19–Related Concerns — United States, June 2020. MMWR Morb Mortal Wkly Rep. 2020;69:1250–1257.
  6. 6. World Health Organization.Cancer.https://www.who.int/health-topics/cancer#tab=tab_1. [cited 2021 August 02]. [Internet].
  7. 7. World Health Organization. Noncommunicable diseases.https://www.who.int/news-room/fact-sheets/detail/noncommunicable-diseases3. [cited 2021 August 02]. [Internet].
  8. 8. European Cancer Organization. Covid-19 & Cancer Data Intelligence.https://www.europeancancer.org/timetoact/impact/data intelligence. [cited 2021 August 02].[Internet].

Ayrıntılar

Birincil Dil

İngilizce

Konular

Sağlık Kurumları Yönetimi

Bölüm

Araştırma Makalesi

Yazarlar

Yayımlanma Tarihi

1 Ekim 2022

Gönderilme Tarihi

5 Eylül 2022

Kabul Tarihi

28 Eylül 2022

Yayımlandığı Sayı

Yıl 2022 Cilt: 44 Sayı: 3

DOI

https://doi.org/10.7197/cmj.1171410

IZ

https://izlik.org/JA42UC23PK

Kaynak Göster

RIS / Bibtex
AMA
1.Çelikgün S, Koç T, Uçku R. Cancer Incidence During The Covid-19 Pandemic In A Middle Anatolian City In Turkey. CMJ. 2022;44(3):288-295. doi:10.7197/cmj.1171410